Annual Cash & Cash Equivalents:
$35.00M+$30.00M(+600.00%)Summary
- As of today, RXO annual cash & cash equivalents is $35.00 million, with the most recent change of +$30.00 million (+600.00%) on December 31, 2024.
- During the last 3 years, RXO annual cash & cash equivalents has risen by +$6.00 million (+20.69%).
- RXO annual cash & cash equivalents is now -64.29% below its all-time high of $98.00 million, reached on December 31, 2022.
Performance
RXO Cash and Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Cash & Cash Equivalents:
$26.00M+$7.00M(+36.84%)Summary
- As of today, RXO quarterly cash & cash equivalents is $26.00 million, with the most recent change of +$7.00 million (+36.84%) on September 30, 2025.
- Over the past year, RXO quarterly cash & cash equivalents has dropped by -$29.00 million (-52.73%).
- RXO quarterly cash & cash equivalents is now -87.74% below its all-time high of $212.00 million, reached on June 1, 2022.
Performance
RXO Quarterly Cash & Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
RXO Cash and Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +600.0% | -52.7% |
| 3Y3 Years | +20.7% | -86.1% |
| 5Y5 Years | - | - |
RXO Cash and Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -64.3% | +600.0% | -86.1% | +420.0% |
| 5Y | 5-Year | -64.3% | +600.0% | -87.7% | +420.0% |
| All-Time | All-Time | -64.3% | +600.0% | -87.7% | +420.0% |
RXO Cash and Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $26.00M(+36.8%) |
| Jun 2025 | - | $19.00M(+18.8%) |
| Mar 2025 | - | $16.00M(-54.3%) |
| Dec 2024 | $35.00M(+600.0%) | $35.00M(-36.4%) |
| Sep 2024 | - | $55.00M(+685.7%) |
| Jun 2024 | - | $7.00M(0.0%) |
| Mar 2024 | - | $7.00M(+40.0%) |
| Dec 2023 | $5.00M | $5.00M(-95.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $104.00M(-16.1%) |
| Jun 2023 | - | $124.00M(+2.5%) |
| Mar 2023 | - | $121.00M(+23.5%) |
| Dec 2022 | $98.00M(+237.9%) | $98.00M(-47.6%) |
| Sep 2022 | - | $187.00M(-11.8%) |
| Jun 2022 | - | $212.00M(+631.0%) |
| Dec 2021 | $29.00M(-58.6%) | - |
| Dec 2021 | - | $29.00M |
| Dec 2020 | $70.00M | - |
FAQ
- What is RXO, Inc. annual cash & cash equivalents?
- What is the all-time high annual cash & cash equivalents for RXO, Inc.?
- What is RXO, Inc. annual cash & cash equivalents year-on-year change?
- What is RXO, Inc. quarterly cash & cash equivalents?
- What is the all-time high quarterly cash & cash equivalents for RXO, Inc.?
- What is RXO, Inc. quarterly cash & cash equivalents year-on-year change?
What is RXO, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of RXO is $35.00M
What is the all-time high annual cash & cash equivalents for RXO, Inc.?
RXO, Inc. all-time high annual cash & cash equivalents is $98.00M
What is RXO, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, RXO annual cash & cash equivalents has changed by +$30.00M (+600.00%)
What is RXO, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of RXO is $26.00M
What is the all-time high quarterly cash & cash equivalents for RXO, Inc.?
RXO, Inc. all-time high quarterly cash & cash equivalents is $212.00M
What is RXO, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, RXO quarterly cash & cash equivalents has changed by -$29.00M (-52.73%)